TRVN Short Sale

Short selling TRVN Stock on FDA Consideration PR.

TRVN (Trevena Inc.) ran almost 100% on news that a new drug was accepted by the FDA for potential approval. This was mistaken as a complete approval announcement by investors, and the resulting spike gave a quick short sale opportunity into the open.